Abstract
With all of the buzz swirling about buprenorphine — the victory of eliminating the X‐waiver claimed by Congress, the White House, the American Society of Addiction Medicine, the U.S. Department of Health and Human Services, the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Administration, and on and on — what is the main organization dedicated to the treatment of opioid use disorder (OUD) with methadone (and buprenorphine), i.e., the American Association for the Treatment of Opioid Dependence (AATOD), up to? AATOD is looking carefully at, and responding to, the Part 8 Notice of Proposed Rulemaking (NPRM), which makes methadone treatment much more accessible and flexible than it was.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
